HealthQuill FDA clearance
A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is underway in US research institutions as the overall disease population is expected to reach 783 million people by 2045.
Health Pharma

Dexcom’s 15-day G7 sensor for glucose monitoring wins FDA nod

HQ Team April 11, 2025: For people living with diabetes, glucose sensors for monitoring sugar levels are a game changer. The present ones.

Read More
cigarette smoke
Drugs Health Pharma

US drug regulator clears Qnovia’s nicotine inhaler for clinical testing

HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Health Medical Pharma

FDA clears Abbott’s rapid blood test for concussion assessment

HQ  Team April 18, 2024: The Food and Drug Administration (FDA) has cleared Abbot’s i-STAT TBI cartridge for rapid assessment of mild traumatic.

Read More